Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 Neoplasm Metastasis 7 Neoplasms 5 Carcinoma, Renal Cell 3 Tuberous Sclerosis 2 Triple Negative Breast Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Neuroendocrine Tumors 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Neuroendocrine 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Sarcoma 1 Renal Cell Cancer Metastatic 1 Relapsed Pediatric Solid Tumor 1 Ovarian Neoplasms 1 Osteosarcoma 1 Nasopharyngeal Carcinoma 1 Metatropic dwarfism 1 Melanoma 1 Lymphoma 1 Liver Neoplasms 1 Liver Failure 1 Liver Diseases 1 Liver Cirrhosis 1 Leukemia, Myelomonocytic, Acute 1

Interventions

Everolimus 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Malignancies × Everolimus × Clear all

NCT01079702 2010-03-03

m-TOR

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Unknown

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡